Your browser doesn't support javascript.
loading
Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T Cells.
Reid, Tara B; Godornes, Charmie; Campbell, Victoria L; Laing, Kerry J; Tantalo, Lauren C; Gomez, Alloysius; Pholsena, Thepthara N; Lieberman, Nicole A P; Krause, Taylor M; Cegielski, Victoria I; Culver, Lauren A; Nguyen, Nhi; Tong, Denise Q; Hawley, Kelly L; Greninger, Alexander L; Giacani, Lorenzo; Cameron, Caroline E; Dombrowski, Julia C; Wald, Anna; Koelle, David M.
Afiliação
  • Reid TB; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Godornes C; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Campbell VL; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Laing KJ; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Tantalo LC; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Gomez A; Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
  • Pholsena TN; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Lieberman NAP; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Krause TM; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Cegielski VI; Department of Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
  • Culver LA; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Nguyen N; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Tong DQ; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Hawley KL; Department of Medicine and Pediatrics, UConn Health, Farmington, Connecticut, USA.
  • Greninger AL; Division of Infectious Diseases, Connecticut Children's, Hartford, Connecticut, USA.
  • Giacani L; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Cameron CE; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Dombrowski JC; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
  • Wald A; Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Koelle DM; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
J Infect Dis ; 2024 Jun 27.
Article em En | MEDLINE | ID: mdl-38932740
ABSTRACT

BACKGROUND:

Histologic and serologic studies suggest the induction of local and systemic Treponema pallidum-specific CD4+ T-cell responses to T. pallidum infection. We hypothesized that T. pallidum-specific CD4+ T cells are detectable in blood and in the skin rash of secondary syphilis and persist in both compartments after treatment.

METHODS:

Peripheral blood mononuclear cells collected from 67 participants were screened by interferon-γ (IFN-γ) ELISPOT response to T. pallidum sonicate. T. pallidum-reactive T-cell lines from blood and skin were probed for responses to 89 recombinant T. pallidum antigens. Peptide epitopes and HLA class II restriction were defined for selected antigens.

RESULTS:

We detected CD4+ T-cell responses to T. pallidum sonicate ex vivo. Using T. pallidum-reactive T-cell lines we observed recognition of 14 discrete proteins, 13 of which localize to bacterial membranes or the periplasmic space. After therapy, T. pallidum-specific T cells persisted for at least 6 months in skin and 10 years in blood.

CONCLUSIONS:

T. pallidum infection elicits an antigen-specific CD4+ T-cell response in blood and skin. T. pallidum-specific CD4+ T cells persist as memory in both compartments long after curative therapy. The T. pallidum antigenic targets we identified may be high-priority vaccine candidates.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article